Maximum Allowable Contrast Dose and Risk of Acute Kidney Injury After Coronary Procedures
Catheterization and Cardiovascular Interventions · 2026
DOI: 10.1002/ccd.70854 ↗Kurz gefasst
Fachartikel in der Zeitschrift Catheterization and Cardiovascular Interventions, 2026. Verfasst von Harshita Gaba und 6 weiteren Autor:innen. Beteiligte Einrichtung: University of Washington, Seattle, Washington, USA. Hauptthemen laut MEDLINE: Acute Kidney Injury, Contrast Media, Coronary Angiography, Percutaneous Coronary Intervention. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Recent studies have questioned whether iodinated contrast is causally related to acute kidney injury (AKI). AIM We pursed a contemporary analysis to determine the impact of contrast dose on AKI following coronary procedures in an era of lower contrast doses and less nephrotoxic agents.
Methods
This national cohort study examined patients who had percutaneous coronary intervention (PCI) or diagnostic angiography from October 2010 to May 2023. We used logistic regression to test associations between (1) baseline (pre‐procedural) AKI risk and contrast dose, and (2) contrast dose and post‐procedure AKI. Contrast exposure was quantified as a proportion of the maximal allowable contrast dose (MACD; 2.5 mL × body weight (kg)/serum creatinine).
Results
Median contrast volume decreased during our study period for PCI (200 to 150 mL, p < 0.01) and angiography (95 to 60 mL, p < 0.01). In the combined cohort of 175,963 procedures, the mean patient age was 68.5 years; 97.5% were male. Decile plots revealed that patients at higher baseline risk of AKI received lower contrast volumes. When the contrast dose exceeded MACD, there was a stepwise association between contrast dose and adjusted odds of AKI. The highest odds of AKI were observed for patients with eGFR < 30 who received > 200% of the MACD (OR, 2.89; 95% CI, 2.21 to 3.79).
Conclusions
In this large national cohort of patients undergoing coronary procedures, there was a reduction in contrast dose over time and evidence that physicians are reducing contrast volume for high‐risk patients. The MACD remains a reasonable target to reduce AKI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University of Washington, Seattle, Washington, USA.
- CART Program, Office of Quality and Patient Safety, Veterans Health Administration, Washington, DC, USA.
- Duke University Medical Center, Durham, North Carolina, USA.
- Veterans Affairs Palo Alto Healthcare System, Palo Alto, California, USA.
- Stanford University School of Medicine, Stanford, California, USA.
- Rocky Mountain Regional VA Medical Center, Aurora, Colorado, USA.
ORCID-Profile: Harshita Gaba, Celina M Yong
Zitieren
APA
Gaba, H., Mesenbring, E., Chow, C., Rymer, J. A., Yong, C. M., Waldo, S. W., & Doll, J. A. (2026). Maximum Allowable Contrast Dose and Risk of Acute Kidney Injury After Coronary Procedures. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70854
Vancouver
Gaba H, Mesenbring E, Chow C, Rymer JA, Yong CM, Waldo SW, et al. Maximum Allowable Contrast Dose and Risk of Acute Kidney Injury After Coronary Procedures. Catheterization and Cardiovascular Interventions. 2026. doi:10.1002/ccd.70854
BibTeX
@article{Gaba2026,
author = {Gaba, Harshita and Mesenbring, Elise and Chow, Christine and Rymer, Jennifer A and Yong, Celina M and Waldo, Stephen W and Doll, Jacob A},
title = {Maximum Allowable Contrast Dose and Risk of Acute Kidney Injury After Coronary Procedures},
journal = {Catheterization and Cardiovascular Interventions},
year = {2026},
doi = {10.1002/ccd.70854}
}
EUVIMED